Pediatric Cancers Clinical Trial
Official title:
Palliative Care and Symptom Management for the Pediatric Oncology Patient
NCT number | NCT00675467 |
Other study ID # | 2007-0054 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | May 7, 2008 |
Last updated | April 7, 2016 |
Start date | April 2008 |
Verified date | April 2016 |
Source | M.D. Anderson Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The goal of this study is to learn about the communication, decision-making, symptom
management, emotional adjustment, and spiritual needs of parents and pediatric patients
treated at the Children's Cancer Hospital at M. D. Anderson (MCACC).
Primary Objectives:
1. Determine the palliative care service needs of pediatric cancer patients and their
parents, including communication, decision-making, symptom management, emotional and
spiritual support when receiving treatment for early cancer, treatment for advanced
disease, and treatment in the end-of-life period.
2. Identify intra-group differences in the categories listed in Objective 1 for pediatric
cancer patients receiving treatment (a) for early cancer, (b) for advanced disease, and
(c) at end-of-life.
Secondary Objectives:
1. Inform the development of a Pediatric Palliative Care Program at the Children's Cancer
Hospital at The University of Texas M. D. Anderson Cancer Center (MCACC or MDACC) based on
identified needs as determined by primary study aims 1 and 2.
Status | Completed |
Enrollment | 13 |
Est. completion date | |
Est. primary completion date | April 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 10 Years to 18 Years |
Eligibility |
Inclusion Criteria: Inclusion for Children: - 10-18 years of age - MD Anderson Children's Cancer Center (MCACC) cancer patient - receiving anti-cancer treatment for disease that is not recurrent or metastatic for cancer diagnosed in the past 3-12 mos or receiving anti-cancer treatment for recurrent or metastatic cancer diagnosed within the past 3-12 months - speak & understand English - reside in the Greater Houston area - provide IRB-approved pediatric assent or informed consent, as age appropriate - if < 18 years of age, provide Internal Review Board (IRB)-approved parental permission - child's eligibility is not contingent upon parent's decision to participate Inclusion for parents: - self-identified parent(s) that has(have) a child eligible for study, per the inclusion and exclusion criteria noted above or has had a child (0-18 yrs of age at time of death) treated for cancer at MCACC who has died in the last 1 to 2 years - speak and understand English - reside in the Houston metropolitan area - provide IRB-approved informed consent - attend different focus groups if more than one eligible parent per child (max 2 parents per child) - parent's eligibility is not contingent upon the child's decision to participate Exclusion Criteria: Exclusion for Children: - have cognitive impairment, developmental delay, or emotional distress that would limit participation in a group discussion, as determined by the clinical judgment of the investigator - younger than 10 years or older than 18 years of age Exclusion for Caregiver: - have cognitive impairment, developmental delay, or emotional distress that would limit participation in a group discussion, as determined by the clinical judgment of the investigator. |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | University of Texas MD Anderson Cancer Center | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
M.D. Anderson Cancer Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Palliative Care Service Needs of Pediatric Cancer Patients + Their Parents | Qualitative data collection. | 3 Years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00575926 -
Lingzhi for Cancer Children
|
Phase 3 | |
Completed |
NCT00588289 -
Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA
|
N/A | |
Completed |
NCT00477256 -
School Reintegration Outcomes in Pediatric Cancer Patients
|
N/A | |
Completed |
NCT01875601 -
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT00883688 -
Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
|
Phase 2 | |
Completed |
NCT02664389 -
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
|
N/A | |
Enrolling by invitation |
NCT02315599 -
Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
|
||
Terminated |
NCT00591539 -
Carotid Artery Disease in Childhood Cancer Survivors
|
N/A | |
Recruiting |
NCT00698113 -
Parent-Delivered Massage in Paediatric Cancer
|
N/A |